ALB and leptospirosis: Patients with leptospirosis present metabolic disturbance with dyslipidemia with a rise in blood NEFA levels and OA/A and oleic + linoleic/albumin molar (OA + L/A) ratios imbalance, which correlates with the disease severity in such patients (Burth et al., 2005; Gazi et al., 2011).